Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
Neuro-Oncology Advances|March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtypeDaniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
The Journal of Urology|June 18, 2013
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient populationR Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, et al.
Neuro-Oncology|October 31, 2019
Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysisCharlie N Saunders, Alex J Cornish, Ben Kinnersley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.
Archives of Pathology & Laboratory Medicine|February 17, 2022
Molecular Biomarker Testing for the Diagnosis of Diffuse GliomasDaniel J Brat, Kenneth Aldape, Julia A Bridge, et al.
The Journal of Molecular Diagnostics : JMD|June 23, 2018
Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in TumorsJennifer L Winters, Jaime I Davila, Amber M McDonald, et al.
Journal of Neuropathology and Experimental Neurology|September 29, 2019
Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial TumorMelissa M Blessing, Patrick R Blackburn, Chandra Krishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Journal of the National Cancer Institute|November 29, 2015
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of GlioblastomaShiv K Gupta, Sani H Kizilbash, Brett L Carlson, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
Neuro-Oncology Advances|March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtypeDaniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
The Journal of Urology|June 18, 2013
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient populationR Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, et al.
Neuro-Oncology|October 31, 2019
Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysisCharlie N Saunders, Alex J Cornish, Ben Kinnersley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.
Archives of Pathology & Laboratory Medicine|February 17, 2022
Molecular Biomarker Testing for the Diagnosis of Diffuse GliomasDaniel J Brat, Kenneth Aldape, Julia A Bridge, et al.
The Journal of Molecular Diagnostics : JMD|June 23, 2018
Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in TumorsJennifer L Winters, Jaime I Davila, Amber M McDonald, et al.
Journal of Neuropathology and Experimental Neurology|September 29, 2019
Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial TumorMelissa M Blessing, Patrick R Blackburn, Chandra Krishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Journal of the National Cancer Institute|November 29, 2015
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of GlioblastomaShiv K Gupta, Sani H Kizilbash, Brett L Carlson, et al.
Pageof 27